Structures by: Muthukumaran J.
Total: 13
Ethyl 6-(4-methoxyphenyl)-1-methyl-4-methylsulfanyl-3-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate
C24H23N3O3S
Acta Crystallographica Section E (2020) 76, 8 1209-1212
a=10.1911(4)Å b=10.7274(6)Å c=11.7692(6)Å
α=98.550(5)° β=105.632(4)° γ=111.015(4)°
Ethyl 3-(4-chlorophenyl)-1,6-dimethyl-4-methylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate
C18H18ClN3O2S
Acta Crystallographica Section E (2020) 76, 3 443-445
a=8.9995(5)Å b=16.7778(11)Å c=12.3595(8)Å
α=90° β=98.892(6)° γ=90°
Heptacarbonyl-1κ^3^<i>C</i>,2κ^4^<i>C</i>-(4-phenylpyridine-1κ<i>N</i>)di- μ-phenyltellurido-1:2κ^4^<i>Te</i>:<i>Te</i>-dirhenium(I)
C30H19NO7Re2Te2
Acta Crystallographica Section E (2010) 66, 5 m518-m519
a=18.549(2)Å b=12.3624(12)Å c=13.7768(11)Å
α=90.00° β=92.927(9)° γ=90.00°
Bis(μ-phenyltellurido-κ^2^<i>Te</i>:<i>Te</i>)bis[tetracarbonylrhenium(I)]
C40H20O16Re4Te4
Acta Crystallographica Section E (2010) 66, 5 m558-m559
a=9.8062(13)Å b=16.3418(15)Å c=17.1000(14)Å
α=106.593(7)° β=99.932(9)° γ=105.572(10)°
6,8-dichloro-<i>N</i>-methyl-3-nitro-4-nitromethyl-4<i>H</i>-chromen-2-amine
C11H9Cl2N3O5
Acta Crystallographica Section E (2011) 67, 4 o898-o899
a=8.7426(7)Å b=9.2727(7)Å c=9.3420(7)Å
α=70.017(7)° β=72.609(7)° γ=87.579(6)°
Butane-1,4-diyl bis(pyridine-4-carboxylate)
C16H16N2O4
Acta Crystallographica Section E (2011) 67, 7 o1803
a=7.8519(5)Å b=10.5284(6)Å c=8.9121(4)Å
α=90.00° β=91.770(5)° γ=90.00°
2,2'-[Naphthalene-1,5-diylbis(nitrilomethanylylidene)]diphenol
C24H18N2O2
Acta Crystallographica Section E (2011) 67, 7 o1765-o1766
a=3.8510(9)Å b=19.395(6)Å c=11.796(2)Å
α=90.00° β=95.85(3)° γ=90.00°
1-(2-Naphthyl)-3-phenyl-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol- 4-yl)propan-1-one
C25H22N2OSe
Acta Crystallographica Section E (2011) 67, 8 o2010-o2011
a=8.0600(4)Å b=10.1215(5)Å c=13.0827(6)Å
α=81.479(4)° β=76.478(4)° γ=82.087(4)°
6-Methoxy-<i>N</i>-methyl-3-nitro-4-nitromethyl-4<i>H</i>-chromen-2-amine
C12H13N3O6
Acta Crystallographica Section E (2011) 67, 5 o1276-o1277
a=6.8354(2)Å b=9.4363(2)Å c=19.9332(4)Å
α=90.00° β=90.777(2)° γ=90.00°
4-{(4-Chlorophenyl)[4-(4-methylphenyl)-1,2,3-selenadiazol-5-yl]methyl}-4,5,6,7- tetrahydro-1,2,3-benzoselenadiazole
C22H19ClN4Se2
Acta Crystallographica Section E (2011) 67, 6 o1421-o1422
a=9.7226(18)Å b=12.969(4)Å c=17.690(3)Å
α=90.00° β=100.959(19)° γ=90.00°
4-[4-(Diethylamino)phenyl]-<i>N</i>-methyl-3-nitro-4<i>H</i>-chromen-2-amine
C20H23N3O3
Acta Crystallographica Section E (2011) 67, 6 o1395-o1396
a=8.9199(11)Å b=10.4333(12)Å c=11.6697(8)Å
α=65.100(9)° β=82.388(8)° γ=69.513(11)°
3-(4-Methylphenyl)-1-phenyl-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol- 4-yl)propan-1-one
C22H22N2OSe
Acta Crystallographica Section E (2011) 67, 7 o1660-o1661
a=8.1485(9)Å b=9.7929(9)Å c=12.1234(13)Å
α=98.707(9)° β=96.387(9)° γ=94.792(9)°
6-Ethyl-<i>N</i>-methyl-3-nitro-4-nitromethyl-4<i>H</i>-chromen-2-amine
C13H15N3O5
Acta Crystallographica Section E (2012) 68, 1 o180-o181
a=8.2538(10)Å b=9.0431(9)Å c=10.3323(12)Å
α=73.484(9)° β=71.728(11)° γ=83.234(9)°